IndraLab

Statements

N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal activates CYLD. 1 / 1

| 1

reach

"Given that CYLD is a well characterized NF-kappaB transcriptional target, and in keeping with results obtained from DLD1, HCT116 and COS7 cells (XREF_SUPPLEMENTARY), there are low expression levels of endogenous CYLD and contrary to RANKL stimulated conditions, CYLD could not be upregulated by MG132 that is largely due to the inhibitory effects of MG132 towards NF-kappaB signaling."

24961988

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal activates CYLD. 1 / 1

INDRA sources:

Databases

Reading